Chemopreventive and Antitumor Efficacy of Curcumin in a Spontaneously Developing Hen Ovarian Cancer Model

dc.contributor.authorŞahin, Kazım
dc.contributor.authorOrhan, Cemal
dc.contributor.authorTuzcu, Mehmet
dc.contributor.authorŞahin, Nurhan
dc.contributor.authorTastan, Hakki
dc.contributor.authorOzercan, Ibrahim Hanifi
dc.contributor.authorOzpolat, Bulent
dc.date.accessioned2026-08-12T17:17:28Z
dc.date.issued2018
dc.departmentFırat Üniversitesi
dc.description.abstractWe investigated the effect of daily dietary curcumin intake on the development and progression of spontaneous ovarian cancer in a galline (hen) model, as the chicken is the only nonhuman animal in which ovarian cancer spontaneously develops with a high prevalence. At the end of 12 months, ovarian cancer had spontaneously developed in 39% (35/90) of control hens not fed curcumin (n = 90). In comparison, it spontaneously developed in 27% (24/90) and 17% (15/90) of hens given curcumin at 25.8 (n = 90) and 53.0 mg/day (n = 90), respectively (P = 0.004). This represented significant dose-dependent reductions in overall ovarian cancer incidence in the 25.8 and 53.0 mg/day curcumin-fed groups (31% and 57%, respectively). Daily curcumin intake also reduced ovarian tumor sizes (P = 0.04) and number of tumors (P = 0.006). Evaluation of the molecular mechanisms underlying the che-mopreventive and antitumor effects of curcumin revealed that NF-kappa B and STAT3 signaling pathways were significantly inhibited but that the nuclear factor erythroid 2/heme oxygenase 1 antioxidant pathway was induced by curcumin intake in a dose-dependent manner in ovarian tissues (P < 0.05). Sequencing of the Ras family genes (KRAS, NRAS, and HRAS) revealed less frequent KRAS and HRAS mutations in ovarian tumors in the curcumin-fed animals. In conclusion, our results demonstrated for the first time that daily curcumin intake leads to a significant and dose-dependent reduction in spontaneous ovarian cancer incidence and tumor growth, indicating a tremendous role for curcumin as a chemopreventive strategy for ovarian cancer. (C) 2017 AACR.
dc.description.sponsorshipNational Scientific and Technological Research Council of Turkey [TUBITAK-113O62]
dc.description.sponsorshipThis study was supported by a grant from The National Scientific and Technological Research Council of Turkey (TUBITAK-113O62).
dc.identifier.doi10.1158/1940-6207.CAPR-16-0289
dc.identifier.endpage67
dc.identifier.issn1940-6207
dc.identifier.issn1940-6215
dc.identifier.issue1
dc.identifier.orcid0000-0003-4138-7689
dc.identifier.orcid0000-0002-1329-3143
dc.identifier.orcid0000-0001-8225-1505
dc.identifier.orcid0000-0001-8602-7463
dc.identifier.orcid0000-0001-9542-5244
dc.identifier.pmid29089332
dc.identifier.scopus2-s2.0-85040318252
dc.identifier.scopusqualityQ2
dc.identifier.startpage59
dc.identifier.urihttps://doi.org/10.1158/1940-6207.CAPR-16-0289
dc.identifier.urihttps://hdl.handle.net/11508/52670
dc.identifier.volume11
dc.identifier.wosWOS:000419171600008
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAmer Assoc Cancer Research
dc.relation.ispartofCancer Prevention Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectNf-Kappa-B
dc.subjectFamilial Adenomatous Polyposis
dc.subjectClinical-Trial
dc.subjectLaying Hens
dc.subjectPrevention
dc.subjectExpression
dc.subjectStrategy
dc.subjectPathway
dc.subjectAdenocarcinomas
dc.subjectAngiogenesis
dc.titleChemopreventive and Antitumor Efficacy of Curcumin in a Spontaneously Developing Hen Ovarian Cancer Model
dc.typeArticle

Dosyalar